Manhattan Scientifics Current Ratio 2010-2024 | MHTX
Manhattan Scientifics current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Manhattan Scientifics Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-06-30 |
$0.00B |
$0.00B |
0.02 |
| 2024-03-31 |
$0.00B |
$0.00B |
0.03 |
| 2023-12-31 |
$0.00B |
$0.00B |
0.03 |
| 2023-09-30 |
$0.00B |
$0.00B |
0.05 |
| 2023-06-30 |
$0.00B |
$0.00B |
0.03 |
| 2023-03-31 |
$0.00B |
$0.00B |
0.07 |
| 2022-12-31 |
$0.00B |
$0.00B |
0.11 |
| 2022-09-30 |
$0.00B |
$0.00B |
0.18 |
| 2022-06-30 |
$0.00B |
$0.00B |
0.26 |
| 2022-03-31 |
$0.00B |
$0.00B |
0.31 |
| 2021-12-31 |
$0.00B |
$0.00B |
0.40 |
| 2021-09-30 |
$0.00B |
$0.00B |
0.55 |
| 2021-06-30 |
$0.00B |
$0.00B |
0.66 |
| 2021-03-31 |
$0.00B |
$0.00B |
0.52 |
| 2020-12-31 |
$0.00B |
$0.00B |
0.66 |
| 2020-09-30 |
$0.00B |
$0.00B |
0.34 |
| 2020-06-30 |
$0.00B |
$0.00B |
0.35 |
| 2020-03-31 |
$0.00B |
$0.00B |
0.26 |
| 2019-12-31 |
$0.00B |
$0.00B |
0.27 |
| 2019-09-30 |
$0.00B |
$0.00B |
0.22 |
| 2019-06-30 |
$0.00B |
$0.00B |
0.28 |
| 2019-03-31 |
$0.00B |
$0.00B |
0.03 |
| 2018-12-31 |
$0.00B |
$0.00B |
0.06 |
| 2018-09-30 |
$0.00B |
$0.00B |
0.14 |
| 2018-06-30 |
$0.00B |
$0.00B |
0.07 |
| 2018-03-31 |
$0.00B |
$0.00B |
0.04 |
| 2017-12-31 |
$0.00B |
$0.00B |
0.17 |
| 2017-09-30 |
$0.00B |
$0.00B |
0.35 |
| 2017-06-30 |
$0.00B |
$0.00B |
0.44 |
| 2017-03-31 |
$0.00B |
$0.00B |
1.37 |
| 2016-12-31 |
$0.00B |
$0.00B |
0.65 |
| 2016-09-30 |
$0.00B |
$0.00B |
0.92 |
| 2016-06-30 |
$0.00B |
$0.00B |
1.55 |
| 2016-03-31 |
$0.00B |
$0.00B |
2.74 |
| 2015-12-31 |
$0.01B |
$0.00B |
4.16 |
| 2015-09-30 |
$0.01B |
$0.00B |
5.86 |
| 2015-06-30 |
$0.01B |
$0.00B |
4.35 |
| 2015-03-31 |
$0.01B |
$0.00B |
5.27 |
| 2014-12-31 |
$0.00B |
$0.00B |
1.41 |
| 2014-09-30 |
$0.00B |
$0.00B |
0.66 |
| 2014-06-30 |
$0.00B |
$0.00B |
0.83 |
| 2014-03-31 |
$0.00B |
$0.00B |
0.90 |
| 2013-12-31 |
$0.00B |
$0.00B |
0.34 |
| 2013-09-30 |
$0.00B |
$0.00B |
0.29 |
| 2013-06-30 |
$0.00B |
$0.00B |
0.64 |
| 2013-03-31 |
$0.00B |
$0.00B |
0.38 |
| 2012-12-31 |
$0.00B |
$0.00B |
0.27 |
| 2012-09-30 |
$0.00B |
$0.00B |
0.36 |
| 2012-06-30 |
$0.00B |
$0.00B |
0.39 |
| 2012-03-31 |
$0.00B |
$0.00B |
0.51 |
| 2011-12-31 |
$0.00B |
$0.00B |
0.47 |
| 2011-09-30 |
$0.00B |
$0.00B |
0.46 |
| 2011-06-30 |
$0.00B |
$0.00B |
0.72 |
| 2011-03-31 |
$0.00B |
$0.00B |
0.91 |
| 2010-12-31 |
$0.00B |
$0.00B |
1.12 |
| 2010-09-30 |
$0.00B |
$0.00B |
0.22 |
| 2010-06-30 |
$0.00B |
$0.00B |
0.27 |
| 2010-03-31 |
$0.00B |
$0.00B |
0.45 |
| 2009-12-31 |
$0.00B |
$0.00B |
0.34 |
| 2009-09-30 |
$0.00B |
$0.00B |
0.46 |
| 2009-06-30 |
$0.00B |
$0.00B |
0.33 |
| 2009-03-31 |
$0.00B |
$0.00B |
0.28 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Nanotechnology Equipment and Services |
$0.000B |
$0.000B |
|
Manhattan Scientifics Inc. is a technology solutions provider that focuses on the nanomedicine space. The Company acts as a technology incubator that acquires, develops and commercializes life-enhancing technologies in various fields, with emphasis in the areas of alternative energy, and consumer and commercial electronics. Manhattan has three wholly owned subsidiaries of which Metallicum is the only operating subsidiary; and Tamarack and Teneo are dormant. Metallicum is a nanotechnology start-up company that focuses on the development and manufacture of nanostructured metals for medical implants and other applications. Metallicum's initial products include nanostructured bulk metals and alloys in the form of rod, bar, wire and foil. Manhattan Scientifics Inc. conducts its operations primarily in the United States and has its offices in New Mexico, New York and Montreal.
|
